Neuro Cap Imaging (NCI) A Business Plan of Medical Device for US Market

• Main Authors: Cheng, Wen-Shin, 鄭文欣
• Other Authors: Tsai, Hwei-An
• Format: Others
• Language: en_US
• Published: 2017
• Online Access: http://ndltd.ncl.edu.tw/handle/qqfz4e

碩士 === 國立交通大學 === 企業管理碩士學程 === 105 === The incidence of stroke has increased dramatically year by year. According to the World Health Organization (WHO), cardiovascular disease caused about one-third of the total global deaths (17.1 million worldwide), of which 43.2% is heart disease (about 7.39 million), 39% is stroke (about 6.67 million people), making stroke become the second most severe cause of death, behind heart disease. The estimation for global stroke will be doubled in 2030. According to the two studies published by The Lancet Medical Journal, the 2030 stroke-induced death, inconvenience and sickness cases may be multiplied, and the age of stroke patients will be younger. According to the study, over the past 20 years, the number of stroke patients age between 20 to 64 years old increased to 31%, of which 67% was cerebral infarction, 14% was cerebral hemorrhage, 4% was subarachnoid hemorrhage and others was unrecognized stroke types. However, in the golden first three hours of diagnosis, if the patient is not properly treated, he would probably miss the opportunity for rehabilitation. This business plan is implemented in the US as our main target market. Combining with relevant recommendations form industrial experts through a viable business plan for Neuro Cap Imaging (NCI), this product has already had patent right and prototype. It will be equipped in ambulances, remote areas clinics, and other medical systems. By using real-time detection and other technologies to shorten the stroke detection time in order to facilitate in remote areas or low-density population, such as: Europe, the United States, China, patients may have more opportunities to be diagnosed and treated correctly within three hours.